BRIEF-Exini Diagnostics applies for voluntary removal of shares from trading on First North
November 17, 2015 at 01:12 AM EST
* Said on Monday at the request of Progenics Pharmaceuticals, Inc, the board of Exini has resolved to apply for voluntary removal of the shares from trading on First North
